Chemring Group PLC (CHG)
London Exchange · UK · prices in GBX · close of 21 Oct 2026
Key indicators
| Last close | GBX 538.00 |
|---|---|
| 52-week range | 444.54 – 647.86 |
| Return, 1 month / 3 months | +0.3% / −10.2% |
| Return, 1 year / 3 years | −4.6% / +104.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 54 |
| Volatility (1 year) | 31.6% |
| Worst drawdown (1 year) | -21.4% |
| Average daily value traded | 506.77M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Chemring Group is a defence and aerospace company based in the United Kingdom. It supplies military customers with countermeasures such as flares and decoys that protect aircraft and ships, along with sensors, electronics and energetic materials used in defence equipment. Its products also serve security and space markets, and the company operates through divisions focused on countermeasures and sensors, serving armed forces and government agencies in several countries.
Chemring Group PLC trades under the code CHG on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Chemring Group PLC (CHG) trades on the London Exchange in UK. It last closed at GBX 538.00 on 21 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 1,756 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 4.6% and over the last three months it fell 10.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 54 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.3% | ||
| From 52-week high | -15.3% | ||
| Momentum | 35 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.2% | ||
| 6-month return | -0.8% | ||
| 12-month return, skipping the last month | -4.9% | ||
| Stability (higher is calmer) | 63 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 31.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.4% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 506.77M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 23 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +5.1% |
|---|---|
| 1 month | +0.3% |
| 3 months | −10.2% |
| 6 months | −0.8% |
| 1 year | −4.6% |
| 3 years | +104.2% |
| 5 years | +96.2% |
Signals
| 50-day / 200-day average | 543.82 / 530.94 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 17.82 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | GBP 0.0280 |
| 19 Mar 2026 | GBP 0.0530 |
| 14 Aug 2025 | GBP 0.0270 |
| 20 Mar 2025 | GBP 0.0520 |
| 15 Aug 2024 | GBP 0.0260 |
| 21 Mar 2024 | GBP 0.0460 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.